-
- Stock symbol: NASDAQ: BIIB
- Annual revenue (2007): $2.26 billion US
- Year Established: 2003
- Industry: Biotechnology
- Phone: 617-679-2000
- Fax: 617-679-2617
- HQ: Cambridge, Massachusetts
- President and CEO: James C. Mullen
- Staff: 4,166
- Products: Rituxan, Zevalin, Avonex, Tysabri
-
-
Biogen Idec, founded in 2003 after a merger between Biogen and Idec Pharmaceuticals, is a biotechnology company that manufactures drugs to treat diseases such as Multiple Sclerosis, AIDS and Cancer. They have manufacturing plants in Kendall Square, in Research Triangle Park, North Carolina and Hoofddorp, Netherlands.
-
Key Dates
- 2003: Biogen Idea is founded after merger between Biogen and Idec Pharmaceuticals
- 2003: Ground-breaking in Denmark for a manufacturing plant
- 2004: Construction completed San Diego Research and Corporate Campus
- 2005: Suspended production and distribution of Tysabri
- 2008: FDA approves Tysabri
-
Biogen Idec on Amazon
-
Sales likely to soar for new MS drug; Tysabri to be first drug for Biogen Idec's Oceanside plant.: An article from: San Diego Business Journal - $5.95
This digital document is an article from San Diego Business Journal, published by CBJ, L.P. on December 6, 2004. The length of the article is 676 words. The page length shown above...Amazon
-
Students step inside a scientist's world at Biogen Idec's Community Labs: teachers challenge their pupils to think about life sciences and future careers.: An article from: San Diego Business Journal - $9.95
This digital document is an article from San Diego Business Journal, published by Thomson Gale on May 7, 2007. The length of the article is 832 words. The page length shown above i...Amazon
-
CELL THERAPEUTICS ACQUIRES ZEVLIN FROM BIOGEN IDEC.: An article from: Worldwide Biotech - $9.95
This digital document is an article from Worldwide Biotech, published by Thomson Gale on February 1, 2008. The length of the article is 1015 words. The page length shown above is b...Amazon
-
-
Idec-Biogen merger still faces big hurdles: new product acquisitions key to long-term success. (Biotech).(Idec Pharmaceuticals Corp., Biogen Inc. merger): An article from: San Diego Business Journal - $5.95
This digital document is an article from San Diego Business Journal, published by CBJ, L.P. on July 7, 2003. The length of the article is 714 words. The page length shown above is ...Amazon
view more products...
-
-
Featured Mahalo Topics
-
On Twitter Powered by Twitter
-
Biogen Idec is Hiring: Director, Marketing - AVONEX (Wellesley, MA) http://bit.ly/3o2sKQ #Jobs #TweetMyJOBS
-
-
Area Business Manager, Neurology - Biogen Idec, Inc. - Grand Rapids, MI: Grand Rapids MI- In this field based, Spe... http://bit.ly/4I6k4V
-
Olga Barreiro ganadora de los IV Premios Fundación Biogen Idec a los Jovenes Investigadores http://bit.ly/63bY96
-
Life Science job postings updated for Novartis, Agilent, BD, Teva, Biogen Idec, Daiichi Sankyo & IPM. Go to www.HireLifeScience.com to apply
view more tweets...
-
About this page
-
Page Views0
No one is currently managing this page.
If you would like to apply
to be the manager of this page, please request below.
If you would like to apply
to be the manager of this page, please request below.
This page currently has no vertical manager.
